Table 1.
Patient characteristics
| Category | |
| Age in months median (range) | 71 (1–207) |
| Sex (male [M]: female [F]) | 93 M:62 F |
| Diagnosis | Patients number | Delay in chemotherapy: median (range) |
|---|---|---|
| Acute lymphoblastic leukemia (ALL) | 52 | 13 (0–105) |
| CNS tumor | 30 | 14 (0–60) |
| Soft tissue sarcoma (STS) | 16 | 12 (0–26) |
| Neuroblastoma | 15 | 15 (0–44) |
| Hodgkin lymphoma (HL) | 10 | 12 (0–15) |
| Renal tumor | 8 | 17 (12–19) |
| Acute myeloid leukemia (AML) | 7 | 17 (0–56) |
| Non-Hodgkin lymphoma (NHL) | 4 | 17 (0–20) |
| Osteosarcoma | 4 | 7 (0–14) |
| Retinoblastoma | 2 | 7 (n/a) |
| Other (EWS, GCT, HCC, LCH, NET, SPN) | 7 | 14 (10–27) |
CNS, central nervous system; EWS, Ewing’s sarcoma; GCT, germ cell tumor; HCC, hepatocellular carcinoma; LCH, Langerhans histiocytosis; NET, neuroendocrine tumor; SPN, solid pseudopapillary neoplasm